insiderwall
Menu
SuperinvestorInsider
Tandem Diabetes Care Inc. TNDM

Super Investor & Insider

Nessuna transazione insider negli ultimi 6 mesi.

Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.

About

Tandem Diabetes Care designs, develops, and commercializes advanced technology solutions for insulin-dependent diabetes management worldwide. The company's flagship products are the t:slim X2 insulin pump and the Tandem Mobi automated insulin delivery system, both featuring Control-IQ or Control-IQ+ hybrid closed-loop

SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees2,650
TickerTNDM

Statistics

Market Cap$1.05B
Revenue (TTM)$1.01B
Net Income-$204.7M
Net Margin-20.2%
EPS$-3.04
P/E-5.46
P/S1.05
P/B6.95
EV/EBITDA-29.55
ROE-65.7%
Dividend Yield
Price$15.37

Data: Twelve Data · Revenue = mcap / P/S